HSIC

HSIC

USD

Henry Schein Inc. Common Stock

$65.300-0.400 (-0.609%)

Precio en Tiempo Real

Healthcare
Medical Distribution
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$65.700

Máximo

$65.835

Mínimo

$64.310

Volumen

0.28M

Fundamentos de la Empresa

Capitalización de Mercado

8.0B

Industria

Medical Distribution

País

United States

Estadísticas de Negociación

Volumen Promedio

1.87M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $60.56Actual $65.300Máximo $82.49

Informe de Análisis de IA

Última actualización: 30 abr 2025
Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

HSIC: Henry Schein Inc. Common Stock - What's Happening and What to Watch

Stock Symbol: HSIC Generate Date: 2025-04-30 22:57:31

Alright, let's break down what's been going on with Henry Schein stock (HSIC) and see what the tea leaves, or rather, the data, might be suggesting. We'll look at the recent news, check out the price chart, and see what the AI models are predicting.

Recent News Buzz

So, what's the word on the street for HSIC lately? We've got a couple of news bits to consider.

First off, there's a note from Piper Sandler, an investment firm. They still think Henry Schein is a stock to "Overweight" – that's analyst talk for "they like it and think it might do better than average." That sounds good, right? But here's the twist: they also lowered their price target for the stock, dropping it from $83 down to $77. So, they still like the company, but maybe not quite as much as they did before, or perhaps they see a slightly lower ceiling on where the price could go in the near term. It's a bit of a mixed signal, leaning cautious because of the lower target.

The other piece of news is about Henry Schein Medical giving out an award to an athletic trainer. This is positive news for the company's image and community involvement. It's nice, feel-good stuff, but honestly, it's probably not the kind of news that moves a big stock price much.

Putting the news together, it's a bit of a mixed bag. The analyst still rates it favorably overall, but the lower price target is a yellow flag. The award news is positive but minor. Interestingly, the AI analysis of recent news sentiment comes back as "highly positive." This suggests the AI might be weighing other factors or interpreting the overall news flow more optimistically than just the analyst note in isolation.

Checking Out the Price Action

Now, let's look at what the stock price itself has been doing over the last month or so. If you check the historical data provided, HSIC has had a pretty rough ride. Back at the start of February, the price was hanging out around the high $70s. Fast forward to today, April 30th, and the price closed around $64.97.

That's a clear downward trend over this period. The stock has lost a significant chunk of its value. It's bounced around a bit within that downtrend, sometimes seeing spikes in volume, but the overall direction has been south. The current price is quite a bit lower than where it was just a couple of months ago, and it's getting closer to its 52-week low than its high.

Putting It All Together: Outlook & Ideas

Okay, so we have a stock that's been trending down, some mixed-to-cautious analyst news (though the AI sees overall positive sentiment), and AI predictions that are looking up. What does this picture suggest?

Based heavily on the AI's take – which points to "significant upside potential," "upward trend," and predicts price increases over the next few days (0.85% today, 2.21% tomorrow, 3.05% the day after) – the apparent near-term leaning seems cautiously positive, if you trust the AI's forecast to outweigh the recent price history and the analyst's lowered target. The AI's confidence in its prediction is noted as high.

So, for someone considering this stock, the AI's view might suggest this downward price action could be presenting a potential buying opportunity.

  • Potential Entry Consideration: The AI recommendation data mentions potential entry points around $66.37 to $66.68, and notes the current price is near a support level of $66.26. Interestingly, the current price ($64.97) is actually below these levels. If you're leaning towards the AI's positive outlook, the current price might look even more attractive than the AI's suggested entry range, as it's already below it. It could be a level to consider if you believe the AI's prediction of an upward move is coming.

  • Potential Exit/Stop-Loss Consideration: To manage risk, the AI suggests a stop-loss level at $59.55. This is a point where, if the price falls below it, the AI's positive outlook might be wrong, and it could be wise to exit to limit losses. For taking profits, the AI suggests a target of $70.13 in the near term, and a potential longer-term target of $80.38. These could be levels to watch if the stock does start moving up as predicted.

A Little Company Context

Just a quick reminder about Henry Schein itself: it's a big player in the Healthcare sector, specifically in Medical Distribution. They supply all sorts of products and services to dental and medical offices. This means their business can be influenced by things like healthcare spending, the health of dental and medical practices, and maybe even things like the award news, though less directly on the stock price. Understanding what the company does helps make sense of why certain news or trends might matter.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Noticias Relacionadas

Analyst Upgrades

Piper Sandler Maintains Overweight on Henry Schein, Lowers Price Target to $77

Piper Sandler analyst Jason Bednar maintains Henry Schein with a Overweight and lowers the price target from $83 to $77.

Ver más
Piper Sandler Maintains Overweight on Henry Schein, Lowers Price Target to $77
BusinessWire

Henry Schein Medical Announces Winner of Its 2025 Rising Star Award

Fifth Annual Award Spotlights Up-and-Coming Athletic Trainers Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (NASDAQ:HSIC), announced today that Ian Jeffer, MS, ATC, LAT, Head Athletic Trainer at

Ver más
Henry Schein Medical Announces Winner of Its 2025 Rising Star Award

Predicción de IABeta

Recomendación de IA

Alcista

Actualizado el: 3 may 2025, 18:21

BajistaNeutralAlcista

67.3% Confianza

Riesgo y Negociación

Nivel de Riesgo3/5
Riesgo Medio
Adecuado Para
Moderado
Guía de Negociación

Punto de Entrada

$65.42

Toma de Ganancias

$66.67

Stop Loss

$58.82

Factores Clave

PDI 6.5 está por encima de MDI 6.1 con ADX 9.5, lo que sugiere una tendencia alcista
El precio actual está extremadamente cerca del nivel de soporte ($65.31), lo que sugiere una fuerte oportunidad de compra
El volumen de operaciones es 12.1 veces el promedio (13,735), lo que indica una presión de compra extremadamente fuerte
El MACD 0.0412 está por debajo de la línea de señal 0.0471, lo que indica un cruce bajista

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.